155 related articles for article (PubMed ID: 8678706)
21. Regulating manufacturer-affiliated communication in the information age.
Schulman KA; Abernethy DR; Rathore SS; Woosley RL
Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
[No Abstract] [Full Text] [Related]
22. US advisory panellists on drug's safety had ties to manufacturers.
Lenzer J; Epstein K
BMJ; 2012 Jan; 344():e244. PubMed ID: 22234908
[No Abstract] [Full Text] [Related]
23. Patient package inserts and the pharmacist's responsibility.
Fink JL
Am J Hosp Pharm; 1979 Feb; 36(2):226-9. PubMed ID: 420215
[TBL] [Abstract][Full Text] [Related]
24. Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events.
Cohen JS
Arch Intern Med; 2001 Apr; 161(7):957-64. PubMed ID: 11295958
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW
Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207
[TBL] [Abstract][Full Text] [Related]
26. Incorrect overdose management advice in the Physicians' Desk Reference.
Mullen WH; Anderson IB; Kim SY; Blanc PD; Olson KR
Ann Emerg Med; 1997 Feb; 29(2):255-61. PubMed ID: 9018192
[TBL] [Abstract][Full Text] [Related]
27. Overpromotion of drugs in international product package inserts.
Osifo NG
Trop Doct; 1983 Jan; 13(1):5-8. PubMed ID: 6836735
[TBL] [Abstract][Full Text] [Related]
28. Silicone gel-filled breast prostheses; silicone inflatable breast prostheses: patient risk information--FDA. Notice.
Fed Regist; 1991 Sep; 56(187):49098-9. PubMed ID: 10170844
[TBL] [Abstract][Full Text] [Related]
29. New female condom clears FDA committee. Next for FDA review: package label and insert.
AIDS Alert; 2009 Apr; 24(4):42-4. PubMed ID: 19382364
[No Abstract] [Full Text] [Related]
30. The rise and fall of Natrecor for congestive heart failure: implications for drug policy.
Kesselheim AS; Fischer MA; Avorn J
Health Aff (Millwood); 2006; 25(4):1095-102. PubMed ID: 16835191
[TBL] [Abstract][Full Text] [Related]
31. Pushing drugs to doctors.
Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
[No Abstract] [Full Text] [Related]
32. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
Chodock R; Yolkut D; Connolly DR
Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
[TBL] [Abstract][Full Text] [Related]
33. Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.
Barton L
J Hosp Mark; 1993; 8(1):71-82. PubMed ID: 10135504
[TBL] [Abstract][Full Text] [Related]
34. The FDA as an information source for family physicians.
Rheinstein PH
Am Fam Physician; 1991 Sep; 44(3):1037-41. PubMed ID: 1877417
[No Abstract] [Full Text] [Related]
35. Off-label promotion: is FDA's final guidance on industry-supported scientific and educational programs enforceable?
Bass IS; Kalb PE; Berenson BA
Food Drug Law J; 1998; 53(2):193-212. PubMed ID: 10346681
[No Abstract] [Full Text] [Related]
36. FDA-USP drug product problem reporting program--an update.
Wheatley LS
Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797
[No Abstract] [Full Text] [Related]
37. Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establishment of a public docket and FDA contact points.
Fed Regist; 1999 Mar; 64(45):11376-7. PubMed ID: 10557625
[TBL] [Abstract][Full Text] [Related]
38. Pitching doctors.
Wilkes MS; Shuchman M
N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
[No Abstract] [Full Text] [Related]
39. [Written drug advertisements--are they reliable?].
Solhaug HR; Indermo H; Slørdal L; Spigset O
Tidsskr Nor Laegeforen; 2006 May; 126(10):1314-7. PubMed ID: 16691265
[TBL] [Abstract][Full Text] [Related]
40. [Physicians' travels abroad supported by drug industry scrutinized. Three cases surveyed by the IGM and the NBL].
Perman E
Lakartidningen; 2003 Dec; 100(51-52):4298-9. PubMed ID: 14756095
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
